Sanj K Patel Insider Trading $GEVA SYNAGEVA BIOPHARMA CORP
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Sanj K Patel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Sanj K Patel. Sanj K Patel is President & CEO in SYNAGEVA BIOPHARMA CORP ($GEVA).
Sanj K Patel in SYNAGEVA BIOPHARMA CORP
Trading Symbol: GEVAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Sanj K Patel: President & CEO
Holdings: 1,031 shares
Latest Transaction: Dec 19 2014
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Sanj K Patel in SYNAGEVA BIOPHARMA CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 19 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | M | 23.00 | 31,448 | 723,304 | 136,052 | |
Dec 19 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | M | 3.52 | 5,016 | 17,656 | 0 | |
Dec 19 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | M | 1.70 | 13,536 | 23,011 | 22,512 | |
Dec 19 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 90.06 | 26,960 | 2,428,018 | 1,031 | 28 K to 1 K (-96.32 %) |
Dec 19 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 87.26 | 4,488 | 391,623 | 27,991 | 32.5 K to 28 K (-13.82 %) |
Dec 19 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 87.55 | 13,536 | 1,185,077 | 32,479 | 46 K to 32.5 K (-29.42 %) |
Dec 19 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 87.25 | 5,016 | 437,646 | 46,015 | 51 K to 46 K (-9.83 %) |
Dec 19 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Buy | M | 23.00 | 31,448 | 723,304 | 51,031 | 19.6 K to 51 K (+160.59 %) |
Dec 19 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Buy | M | 3.52 | 5,016 | 17,656 | 19,583 | 14.6 K to 19.6 K (+34.43 %) |
Dec 19 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Buy | M | 1.70 | 13,536 | 23,011 | 14,567 | 1 K to 14.6 K (+1,312.90 %) |
Jun 05 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | A | 80.35 | 120,000 | 9,642,000 | 120,000 | |
Jan 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | M | 3.52 | 50,971 | 179,418 | 5,016 | |
Jan 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | M | 1.70 | 20,391 | 34,665 | 36,048 | |
Jan 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | M | 0.95 | 6,106 | 5,801 | 0 | |
Jan 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | M | 3.52 | 24,832 | 87,409 | 55,987 | |
Jan 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 91.58 | 400 | 36,632 | 1,031 | 1.4 K to 1 K (-27.95 %) |
Jan 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 90.85 | 1,502 | 136,457 | 1,431 | 2.9 K to 1.4 K (-51.21 %) |
Jan 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 89.27 | 5,600 | 499,912 | 2,933 | 8.5 K to 2.9 K (-65.63 %) |
Jan 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 88.31 | 18,652 | 1,647,158 | 8,533 | 27.2 K to 8.5 K (-68.61 %) |
Jan 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 87.19 | 24,817 | 2,163,794 | 27,185 | 52 K to 27.2 K (-47.72 %) |
Jan 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Buy | M | 3.52 | 50,971 | 179,418 | 52,002 | 1 K to 52 K (+4,943.84 %) |
Jan 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 90.10 | 812 | 73,161 | 1,031 | 1.8 K to 1 K (-44.06 %) |
Jan 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 88.95 | 8,402 | 747,358 | 1,843 | 10.2 K to 1.8 K (-82.01 %) |
Jan 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 88.38 | 32,609 | 2,881,983 | 10,245 | 42.9 K to 10.2 K (-76.09 %) |
Jan 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 87.16 | 9,506 | 828,543 | 42,854 | 52.4 K to 42.9 K (-18.16 %) |
Jan 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Buy | M | 1.70 | 20,391 | 34,665 | 52,360 | 32 K to 52.4 K (+63.78 %) |
Jan 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Buy | M | 3.52 | 24,832 | 87,409 | 31,969 | 7.1 K to 32 K (+347.93 %) |
Jan 30 2014 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Buy | M | 0.95 | 6,106 | 5,801 | 7,137 | 1 K to 7.1 K (+592.24 %) |
Jul 29 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | M | 3.52 | 15,895 | 55,950 | 80,819 | |
Jul 29 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | M | 1.70 | 16,882 | 28,699 | 56,439 | |
Jul 29 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | M | 3.52 | 35,308 | 124,284 | 96,714 | |
Jul 29 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | M | 1.70 | 20,000 | 34,000 | 73,321 | |
Jul 29 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | M | 0.95 | 3,664 | 3,481 | 6,106 | |
Jul 29 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | M | 0.95 | 8,251 | 7,838 | 0 | |
Jul 29 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 47.39 | 15,895 | 753,264 | 1,031 | 16.9 K to 1 K (-93.91 %) |
Jul 29 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Buy | M | 3.52 | 15,895 | 55,950 | 16,926 | 1 K to 16.9 K (+1,541.71 %) |
Jul 29 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 48.31 | 17,204 | 831,125 | 1,031 | 18.2 K to 1 K (-94.35 %) |
Jul 29 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 47.91 | 52,190 | 2,500,423 | 18,235 | 70.4 K to 18.2 K (-74.11 %) |
Jul 29 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Buy | M | 1.70 | 16,882 | 28,699 | 70,425 | 53.5 K to 70.4 K (+31.53 %) |
Jul 29 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Buy | M | 3.52 | 35,308 | 124,284 | 53,543 | 18.2 K to 53.5 K (+193.63 %) |
Jul 29 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 48.73 | 14,711 | 716,867 | 18,235 | 32.9 K to 18.2 K (-44.65 %) |
Jul 29 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Buy | M | 1.70 | 20,000 | 34,000 | 32,946 | 12.9 K to 32.9 K (+154.49 %) |
Jul 29 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Buy | M | 0.95 | 3,664 | 3,481 | 12,946 | 9.3 K to 12.9 K (+39.47 %) |
Jul 29 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Buy | M | 0.95 | 8,251 | 7,838 | 9,282 | 1 K to 9.3 K (+800.29 %) |
Jun 13 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | M | 1.70 | 14,731 | 25,043 | 93,321 | |
Jun 13 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | M | 0.95 | 25,621 | 24,340 | 9,770 | |
Jun 13 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | M | 0.95 | 6,105 | 5,800 | 35,391 | |
Jun 13 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | M | 0.95 | 23,543 | 22,366 | 8,251 | |
Jun 13 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 40.48 | 40,352 | 1,633,449 | 1,031 | 41.4 K to 1 K (-97.51 %) |
Jun 13 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Buy | M | 1.70 | 14,731 | 25,043 | 41,383 | 26.7 K to 41.4 K (+55.27 %) |
Jun 13 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Buy | M | 0.95 | 25,621 | 24,340 | 26,652 | 1 K to 26.7 K (+2,485.06 %) |
Jun 13 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Sell | S | 40.89 | 29,648 | 1,212,307 | 1,031 | 30.7 K to 1 K (-96.64 %) |
Jun 13 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Buy | M | 0.95 | 6,105 | 5,800 | 30,679 | 24.6 K to 30.7 K (+24.84 %) |
Jun 13 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Buy | M | 0.95 | 23,543 | 22,366 | 24,574 | 1 K to 24.6 K (+2,283.51 %) |
Jun 10 2013 | GEVA | SYNAGEVA BIOPHARMA ... | Patel Sanj K | President & CEO | Option Exercise | A | 40.32 | 128,000 | 5,160,960 | 128,000 |
Page: 1